IMPORTANCE Germline variants in the MC1R gene are common and confer moderate melanoma risk in those with varied skin types. Approaches to precision skin cancer prevention that include genetic information may promote risk awareness and risk reduction in the general population, including Hispanics.
M elanoma is a common malignant neoplasm, and disproportionate increases in melanoma, particularly thicker tumors with poorer prognoses, have been documented in Hispanics in states with high levels of yearround sun exposure.
1,2 In ethnically and racially diverse populations, melanoma results in greater morbidity and mortality due to the disease often being identified at later stages, and because of low physician and patient awareness that melanomas occur in these populations. Variants of the melanocortin-1 receptor gene (MC1R) confer moderate melanoma and basal cell cancer risks in the general population. 13 This gene is located on the long arm of chromosome 16 and is related to cutaneous pigmentation (eg, fair skin, red hair) [14] [15] [16] and has effects unrelated to UV exposure.
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A great deal of accumulated evidence, including systematic analyses of candidate genes, genome-wide association studies, and a meta-analysis of 12 melanoma case-control studies involving 6000 individuals, 18 has identified 9 risk variants for melanoma with odds ratios ranging from 1.42 (95% CI, 1.09-1.85) to 2.45 (95% CI, 1.32-4.55). 19 Importantly, variation in MC1R is associated with melanoma risk after adjustment for hair color and skin type. 15, 16, 20, 21 MC1R predicts melanoma risk in Spanish [22] [23] [24] and Mediterranean populations, 16, [25] [26] [27] with several studies indicating that MC1R may confer greater risk in individuals with a darker compared with lighter phenotype.
28
Across Hispanic and non-Hispanic populations, approximately 60% to 70% of individuals have at least 1 risk variant. 20, 22, 28 As such, there is potential for MC1R feedback to motivate sun protection behavior in diverse population subgroups.
29
The present study is drawn from a randomized clinical trial (RCT) examining reach and utility of MC1R testing in a diverse primary care setting in Albuquerque, New Mexico. Hispanics in Albuquerque, New Mexico, have substantial Spanish ancestry, 30,31 so we expected to find a relatively high frequency of risk variants across Hispanic and non-Hispanic study participants. 22 Over the past decade, the rapid pace of discovery of risk-influencing genes and the use of the internet as an important source of health information have evolved in parallel. Thus, for the RCT we developed internet delivery of information regarding MC1R testing, and participants could only order a saliva test kit online (see Hay et al 32 or the Supplement for full trial methods). To date, uptake of internet direct-to-consumer personalized genomic testing has generally been concentrated among white, highly educated consumers. 33 The literature examining responses to genetic information in Hispanics is limited, yet there are promising indications that Hispanics may have high interest in learning more about their genetic risks of developing cancers. 34, 35 Research has identified potential barriers to genetic risk communication in Hispanics, such as health literacy, language, and access, 36 as well as potential facilitators of use such as a cultural orientation prioritizing family relationships and communication. 37 All RCT study materials (website, risk feedback, surveys) were available in Spanish as well as English.
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There were 2 study aims: (1) to examine interest and uptake of MC1R testing and (2) to examine demographic and skin cancer risk factor covariates of interest and uptake of MC1R testing. These findings can be used to help shape the public health translation of personalized genomic testing for melanoma as it may become more widely available in coming years.
Methods

Participants
Bilingual project assistants approached primary care patients in the University of New Mexico (UNM) outpatient primary care clinics with invitation flyers (English and Spanish) and National Cancer Institute skin cancer information for diverse skin types (available in English and Spanish versions; Anyone Can Get Skin Cancer).
39 Patients were eligible if they were registered in any UNM clinic for at least 6 months, assigned a UNM primary care physician, aged 18 years or older, and fluent in English or Spanish. Those who were eligible but refused study participation completed a 1-minute refuser survey that assessed reasons for refusal and demographic characteristics (ethnicity, race, sex, educational attainment, and age). All study procedures and materials were approved by the UNM institutional review board.
Procedure
Eligible patients completed written informed consent and a baseline assessment and were randomized to an invitation to consider personalized genomic testing (via MC1R) for skin cancer risk via logging onto the study website or to usual-care control (randomized 5:1; balanced across Hispanic vs nonHispanic ethnicity). Usual-care controls did not receive an invitation to log on. Those randomized to the intervention arm could log onto the study website to read the 3 educational modules regarding MC1R testing and then register a test decision.
Key Points
Question What are the prevalence and patterns of interest in MC1R testing in a diverse, primary care population?
Findings In this randomized clinical trial that included 499 adults receiving an invitation to consider MC1R testing, nearly half logged on to the study website to consider testing; non-Hispanic whites and those with higher educational attainment were most likely to be interested in testing, compared with Hispanics and those with lower educational attainment.
Meaning Genetic testing for common variation in skin cancer risk may be acceptable in the general population; addressing potential for reduced utilization in minority and less educated individuals may be warranted.
Those without internet access were also offered the opportunity to view the website via paper form.
Measures
Outcome measures, including registration of a test decision (yes vs no), request of a saliva test kit (yes vs no), and return of a test kit (yes vs no), were assessed as primary assessments of study interest and uptake. Predictor measures were as follows. All participants completed baseline assessments that included their ethnicity, race, sex, educational attainment, age, birth country, marital status, employment status, income, and internet access (ever; home). Skin cancer risk factors were assessed and included personal cancer history (cancer in general; skin cancer), family history of skin cancer, and skin type (burnability, tannability, and sunburn history [yes vs no; lifetime number] 40 ).
Statistical Approach
Participant characteristics were reported overall and by ethnicity, and differences by ethnicity were tested using independent-samples t test for age and χ 2 tests for other characteristics. Descriptive statistics were calculated for website log on (yes vs no), requesting a test kit (yes vs no), and providing a saliva sample for MC1R testing (yes vs no). We evaluated unadjusted and adjusted logistic regression models examining predictors of each of these outcomes. Next, an ordinal outcome 41 representing extent of test follow-through was calculated and modeled using unadjusted and adjusted ordinal logistic regression models to examine each predictor (0 = no log on; 1 = log on only; 2 = log on and test kit request but failure to return it; 3 = log on, test request, and saliva kit return).
Ordinal logit models are interpreted such that the odds ratio indicates the odds of more vs less extensive test followthrough; ordinal logit models assume the proportional odds assumption, 42 which we tested via the score χ 2 test. 43 For all outcomes, the adjusted model was built starting with individually significant predictors from the unadjusted models, and using a backward technique with Akaike information criteria to reduce to the best-fit model. The α level was set to .05 and all tests were 2 sided. All statistics were conducted in SAS, version 9.4.
Results
The project assistants approached 1998 primary care patients, and 917 (46%) agreed to be screened for eligibility. Ineligibility (n = 191) was primarily due to being a registered UNM patient for less than 6 months (166 [87%]) or not having a primary care provider (36 [19%] 
Prevalence and Predictors of MC1R Testing Interest and Uptake
As reported in Table 2 , almost half of participants (232 [46%] ) accepted the invitation and logged onto the study website (18 of the 232 viewed the study website via paper form, as per their preference). Website log on rate was higher in non-Hispanic whites compared with Hispanics, and higher in those with higher (greater than high school) compared with lower educational attainment (high school diploma or less). Those with Grade 7-9 15 (3) 15 (6) 0
Grade 10-11 17 (3) 15 (6) 2 (0.8)
High school diploma or GED 81 (16) 59 (24) 22 (9) Some college 125 (25) 77 (32) 48 (19) Associate's degree 45 (9) 22 (9) 23 (9) Standard college or university degree
84 (17) 23 (10) 60 (24) Some graduate school 16 (3) 9 (4) 7 (3)
Graduate degree or professional training
113 (23) 20 (8) 92 ( Internet access (ever; home) were more likely to log on compared with those without access. Skin cancer risk factors were also related to website log on; participants with at least 1 firstdegree relative who had a history of skin cancer and participants with a personal sunburn history were more likely to log on compared with those without these histories. In the adjusted analysis, only 2 variables-race/ethnicity and educationremained significant predictors of website log on. Most participants (204 of 232 [88%]) who logged onto the website decided to request the saliva test kit. The remainder either refused testing (13 [6%]) or did not register a test decision (15 [6%]). Among participants who logged onto the website, the test kit request rate was higher in non-Hispanic whites, men, those with higher educational attainment, and those with internet access (ever or at home). Additionally, participants with a personal sunburn history were more likely to request a test kit. Adjusted analyses indicated that the most important predictor of test request was having a sunburn history.
Finally, most (167 of 204 [82%]) who requested testing completed and returned the saliva kit. The rate of returning the test kit was higher in non-Hispanic whites and older participants. In the adjusted analysis, neither Hispanic status nor age remained significant.
Predictors of Test Follow-through
As reported in Table 3 , in unadjusted models of the ordinal outcome, race/ethnicity, education, internet access (ever or at home), family history of skin cancer, and personal sunburn history were significant predictors of increasing test follow-through. Specifically, non-Hispanic whites, those with higher educational attainment, those with internet access, those reporting a family history of skin cancer (firstdegree relative or non-first-degree relative), and those with a sunburn history had higher test follow-through. In the adjusted model, race/ethnicity and education remained important predictors.
Discussion
A 2016 report from the National Academy of Sciences highlighted the need to address access issues in genomic medicine. 44 Despite this need, for-profit companies are already marketing and offering genetic testing directly to consumers and although the direct-to-consumer model seeks to increase access, utilization has continued to be concentrated among non-Hispanic white, highly educated consumers. c Other group (n = 106) includes Native Hawaiian/other Pacific Islander (n = 2) and participants who said they were none or more than 1 race (n = 104).
d In subsequent analyses, education is analyzed using the following categories: high school graduate/GED (n = 116) or less education vs some college or more education (n = 383).
e In subsequent analyses, marital status is analyzed using the following categories: single (n = 144) vs married/living with partner (n = 241) vs other (ie, divorced, separated or widowed) (n = 112).
f In subsequent analyses, employment status is analyzed using the following categories: employed/student (n = 251) vs unemployed (n = 26) vs other (ie, on leave/homemaker/disabled/ retired) (n = 221).
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Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population This model has largely bypassed behavioral research that could ensure broad utility and reach of this technology to diverse populations, arguing for the time-sensitive need to develop an empirical basis to maximize the benefits and minimize the harms of genomic feedback, even as evidence for specific gene variants and panels inevitably shifts over time. Psychosocial research has highlighted interest in, and outcomes of, genetic testing in high-risk families who present in specialized clinics and receive extensive genetic counseling, 45 such as exceptionally high risk families offered testing for CDKN2A/p16. 46 However, this research has been largely conducted in the context of familial disease, which does not shed light on how the general population will respond to precision skin cancer prevention approaches that may include genetic information.
In the present study, we found moderately high rates of interest and uptake of MC1R testing in a diverse primary care setting. These rates greatly exceed what was found in prior work offering multiplex genetic testing for risk for 8 conditions (including MC1R testing for melanoma risk) 47 in primary care in Detroit, Michigan. For instance, nearly half (46.5%) of our sample logged on to the informational website compared with 30% in prior work; and of those who logged on, 87.9% requested a test kit compared with 50% in prior work.
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Finally, 82% followed through with providing a saliva sample compared with 30% who, in this prior study, came into the clinic to provide a blood sample. Possibly the use of a mailed saliva sample in this study rather than providing a blood sample in the earlier study facilitated testing. Additionally, most (62%) of those who ultimately followed through with testing had anticipated that they were "very likely" to choose testing (as assessed at initial website log on [J.L.H., D.B., K.Z., et al, unpublished data, 2017]) even before reading the website information; as such, the decision to be tested for some participants was made before website log on. Information that was presented in the website may have been instrumental for the 40% who were not certain about testing at enrollment. Given this demonstrated propensity toward testing for those who decided to log on to the website, the findings may not be entirely generalizable to the range of patients who might encounter messages recommending precision testing and counseling for skin cancer outside a medical clinic. Testing rates might well be higher in clinical practice if recommended by physicians. There were some common predictors of interest in and uptake of MC1R testing, as well as test follow-through. Across our study outcome variables, the most important predictors were race/ethnicity and education, with those identifying as Hispanic, as well as those with lower educational attainment, showing lower rates of interest and uptake compared with nonHispanic whites and more highly educated participants, consistent with demographic effects shown for interest in directto-consumer personalized genomic testing. 33 It is important to point out that in the present study skin type variables were confounded with Hispanic status. As such, 181 (71%) nonHispanic white participants reported a sunburn history compared with 108 (45%) Hispanics (P < .001), 112 (44%) nonHispanic white participants reported that they sunburn easily, compared with 82 (34%) Hispanics, and 159 (62%) nonHispanic white participants reported that they tan easily, compared with 163 (67%) Hispanics. Indeed, those with darker skin types often perceive lower risk for melanoma. 3 More research is needed to explore barriers to genomic testing among racially and ethnically diverse and less educated patients, including lack of knowledge, lower genomic literacy, and lack of confidence in the medical system, to achieve maximum benefits of precision prevention for skin cancer and other chronic diseases in the broad population who stand to benefit from such technologies. In the present study, we obtained translations of all our study materials into New Mexican Spanish and conducted preliminary qualitative research to confirm the comprehensibility and acceptability of these materials 38 ; yet further efforts to understand important barriers clearly remain.
Comparatively lower interest in diverse populations might create or perpetuate health disparities in this population, and key a Numbers are counts within the group with affirmative outcomes; for example, the denominator for the Website Log on model is participants who logged on (n = 232).
b Hispanic includes white and nonwhite participants who said they were Hispanic, Latino, or of Spanish descent.
c Other non-Hispanic (n = 35) includes non-Hispanic American Indian/Alaska Natives (n = 8), Asians (n = 10), blacks/African Americans (n = 9), Native
Hawaiian/other Pacific Islander (n = 1), and participants who said they were none or more than 1 of these groups (n = 7).
d Other includes divorced/separated/widowed.
e Other includes on leave/homemaker/disabled/retired.
f Due to the small number who declined to provide their income, these participants were not included in analyses.
g Due to the small number who said "don't know," these participants were not included in analyses.
Research Original Investigation
Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population factors that predict existing health disparities in this population might also be barriers. Importantly, even in those with a high school education or less, a sizable minority (33 [28%]) of participants went to the website to learn about MC1R testing, implying that less educated patients are reachable. In future analyses, we will examine comprehension of and satisfaction with the online information across educational and health literacy levels, which will help dictate future directions in adapting intervention material for diverse populations. The importance of a history of sunburn emerged as an important predictor of participants' decision to order a test kit once they considered the rationale, benefits, and drawbacks of MC1R testing. This indicates that having a history of sunburn is distinctly important in the decision to be tested rather than whether to seek information (log on) on skin cancer genetic testing. In future work, we will explore the psychosocial predictors of interest and uptake for MC1R testing, which will inform work exploring the potential for healthy behavior change after testing for other common genetic markers for melanoma risk.
49
Limitations
There were notable study strengths and limitations. The sample was diverse and large. Also, the outcome measures were behavioral rather than self-reported. The trial was conducted in only 1 primary care health system in an academic setting and in a single location in the American Southwest, which may not fully generalize to other primary care systems. However, we did recruit and have all study materials (including our website) available in Spanish as well as English, 38 setting the stage for dissemination of our MC1R educational website and risk feedback materials in other settings, and across languages. It is possible that we may have differentially recruited those with a Hispanic includes white and nonwhite participants who said they were Hispanic, Latino, or of Spanish descent.
b Other non-Hispanic (n = 35) includes non-Hispanic American Indian/Alaska Natives (n = 8), Asians (n = 10), blacks/African Americans (n = 9), Native Hawaiian/other Pacific Islander (n = 1), and participants who said they were none or more than 1 of these groups (n = 7).
c Other includes divorced/separated/widowed.
d Other includes on leave/homemaker/disabled/retired.
e Due to the small number who declined to provide their income, these participants were not included in analyses.
f Due to the small number who said "don't know," these participants were not included in analyses.
Interest and Uptake of MC1R higher interest in testing; we will explore this possibility in subsequent psychosocial analyses. Although not all refusers (38 of 105) were willing to complete it, inclusion of a refuser survey was a study strength that allows us to clarify some factors related to study participation. Also in subsequent analyses we will examine psychosocial predictors of interest and uptake of MC1R testing.
Conclusions
We document relatively high rates of interest and followthrough for skin cancer genetic testing in primary care. While evidence will continue to accumulate concerning the reliability and utility of such markers in precision skin cancer risk assessments, this study has advanced the public health translation of skin cancer genetic testing in providing insight into how such information may be received in populations unselected for risk status drawn from the general population. While interest and test uptake was higher than in prior work, socioeconomic and demographic patterns in testing emerged. Identification of these disparities represents a valuable step providing guidance for future research to understand underlying mechanisms at play, directing us to identify future solutions to ensure ease of availability of genetic information seeking in the general population. -SC) . The overarching goal of this study is to learn more about how to maximize the availability, comprehension and appropriate uptake of personalized genomics among different populations in New Mexico. Primary Care patients will be recruited in their primary health clinic to complete surveys about their understanding and beliefs of skin cancer and behaviors that might help prevent skin cancer. 6 out of every 7 patients will then be asked to go to a website to learn more about skin cancer risk. Once participants have completed the education modules on this site, participants will be given the option to request and complete a skin cancer genetic testing kit. All participants will be contacted again after three months to complete a follow-up set of surveys about skin cancer.
Detailed Description: This study will have two phases, with an added usability test after Phase I and before Phase 2. Phase 1: Cognitive Interviews in Spanish. Phase 2: Personalized Genomic Testing for Skin Cancer (PGT-SC).
The overarching goal of this study is to learn more about how to maximize the availability, comprehension and appropriate uptake of personalized genomics among different populations in New Mexico. The study has been funded as an R01 by NCI for three years.
Aim I: To examine the personal utility (that is, how does personal genomic testing help the individual) of Personal Genomic Testing for Skin Cancer (PGT-SC) in terms of short-term (three months after testing) sun protection, skin screening (i.e., behaviors), communication, melanoma threat and control beliefs (i.e., putative mediators of behavior change). Guided by Protection Motivation Theory, the investigators hypothesize that behaviors and putative mediators will be higher in those who test, compared to those who decline testing or wait-list controls.
Aim Ia. An important challenge of personal genomics involves the potential for those who receive "negative" genetic feedback to increase risky behaviors. To examine this potential unintended consequence of testing, the investigators will conduct a subgroup analysis among those who receive average risk PGT-SC findings, examining sun protection at three months as the outcome. Predictors will include baseline skin cancer threat and control beliefs, skin cancer risk factors, and demographics. These findings will be used in future studies to develop messages for groups that receive average risk feedback, which accounts for large segments of those tested for moderate risk susceptibility factors across many diseases.
Aim II: To examine differential reach of PGT-SC across Hispanics and NonHispanics, and potential explanations for any differential reach. Reach is defined as the extent to which genomic testing is spread throughout the population. Reach will be measured in individuals as the consideration of the pros and cons of testing and registration of test decision. Additional assessments of reach include baseline survey completion and decision to pursue PGT-SC testing. The investigators hypothesize that those who are self-identified Hispanic will show reduced reach, but that differences in health literacy, health system distrust, and Hispanic sociocultural factors including cancer fatalism, family health orientation, and skin cancer misperceptions will explain differences in reach between Hispanics and Non-Hispanics, and provide guidance for future PGT-SC modifications for Hispanics.
Aim III: Among those who undergo testing, to examine (two weeks after PGT-SC test result receipt) test comprehension, recall, satisfaction, and cancerrelated distress, and whether these outcomes differ by ethnicity (Hispanic versus Non-Hispanic) or health literacy, distrust, sociocultural, or demographic factors. The investigators hypothesize, based on prior work delivering this intervention in primary care, the results will reflect high test comprehension, accurate feedback interpretation, and low test distress in those who get tested.
Background. Personalized genomics currently has extremely limited reach. First, most gene discovery has not engaged diverse research cohorts. Second, the few translational research efforts that address "real world" genomic challenges and opportunities have engaged those with higher socioeconomic status and health literacy. Third, ethnic and racial minorities are less likely to participate in basic genomics research, and are also less likely to utilize available genomic technologies, even when they are offered. Ideally, the investigators should all have fair access to the knowledge gained from sequencing the human genome, but if these trends continue, the investigators will know little about how to maximize availability, comprehension, and appropriate uptake of personalized genomics across large subpopulations that stand to benefit from it.
To begin to address this, The Multiplex Study led by the National Human Genome Research Institute (NHGRI) used population-based recruitment strategies in Detroit, Michigan to evaluate an Internet-provided offer of genomic testing for common diseases, including melanoma, the most serious form of skin cancer. Study findings indicate that this approach is feasible -resulting in high test comprehension, accurate feedback interpretation, and low test distress in those who sought testing. Yet this study did not include Hispanics nor assess behavioral outcomes.
Personalized genomic testing for skin cancer (PGT-SC) is an ideal context to extend Multiplex to a new population, and new outcomes. Skin cancers are preventable, curable, very common in the general population, and disproportionately increasing in Hispanics. The NHGRI Multiplex Study offered testing for melanoma risk via the melanocortin 1 receptor gene (MC1R) because MC1R is common in the general population (50% >1 high risk variant), interacts with sun exposure, and confers risk (2-3 fold; consistent with most moderate risk variants), even in those with darker skin types. MC1R feedback is a promising vehicle to raise risk awareness and protective behavior in the general population, including Hispanics who are largely unaware of their melanoma risks. The investigators will conduct a randomized controlled trial examining internet presentation of the risks and benefits of PGT-SC (shown to be feasible in Multiplex) versus wait-list controls who are not offered testing, comparing personal utility and reach in a general population, English or Spanish-speaking cohort in Albuquerque, New Mexico, where there is yearround sun exposure.
Prior investigator collaborations. This transdisciplinary effort will bring together the combined expertise of investigators -many of whom have productive, longstanding collaborations already -to integrate up-to-date research findings from their respective disciplines, a necessary step given that the rapid unfolding of new cancer genomic, communication, and behavioral science findings is the expected reality of these fields. The investigators employ a Multiple PI Plan. Dr. Jennifer Hay, Principal Investigator is an expert in risk communication and behavior change who has worked with Dr. Marianne Berwick, Principal Investigator, a genetic epidemiologist and a leader in the field of the genetic factors in melanoma for over 10 years. Drs. Hay and Berwick conducted studies examining family communication and health behavior change (screening, sun protection) in melanoma families, and found a high rate of discussion about melanoma risk in melanoma families, that different patterns of family communication after melanoma diagnosis influence adoption of prevention strategies, inconsistent adoption of such strategies in survivors, and that behavioral outcomes associated with hypothetical melanoma genetic testing differ based on positive versus negative risk feedback.
Pilot research conducted by the investigators at the University of New Mexico (UNM) indicate that primary care patients are receptive to skin cancer genomic communication; UNM Hispanics report higher skin cancer misconceptions. Drs. Hay and Berwick conducted this pilot study in the UNM 1209 Clinic to examine 1) patients' receptivity to behavioral research studies in skin cancer and genetics, 2) to document levels of sunscreen and protective clothing use, shade-seeking, and health provider skin cancer screening examinations, 3) to examine prior health information-seeking and family cancer discussions, and 4) prevalence of accurate skin cancer beliefs. Most (71%) participants were female and they ranged in age from 19-81 years (n=50), with racial/ethnic subgroups consistent with the Albuquerque population (46% were Hispanic, 35% were Non-Hispanic White, 6% Native American, 3% African American, and 10% other). Nine percent had not completed high school, and 55% had household incomes less than $30k/year. About one third (30%) reported a family skin cancer history and 7% a personal skin cancer history. About two-thirds (66%) reported interest in behavioral skin cancer research, and while few (17%) had heard of genetic testing marketed directly to consumers, two thirds (76%) said they would be interested in learning more about genetic testing for skin cancer. Sun protection and skin cancer screening levels were consistent with recent national data; 29% reported that they consistently used sunscreen, 62% wore a shirt with sleeves, 34% a hat, and 47% sought shade often or always while outside on a sunny day. Even fewer (26%) had ever received a health provider skin examination. Non-Hispanic Whites reported more consistent use of sunscreen, and were more likely to have received a prior health provider skin examination than Hispanics and other racial/ethnic groups (all p values <0.01). Two-thirds (62%) reported that they were moderately or highly likely to develop skin cancer. Predominant reasons for heightened risk included current or past sun exposure, fair skin, and family history or genetic factors. Spontaneous health information-seeking was common, with 72% reporting that they had ever sought information on medical topics, predominantly via the internet. Over half (62%) had sought cancer information. About half (55%) had talked about cancer risk, and 37% about skin cancer risk, in their family. Those with higher perceived skin cancer risk talked more about it with their family (r=0.34, p=0.001) and were more interested in skin cancer behavioral research participation (r=0.26, p=0.01). The investigators assess skin cancer misconceptions as an explanation for reduced PGT-SC reach in Aim II of the current study, because Hispanics reported more skin cancer misconceptions than Non-Hispanic Whites in the investigators' UNM pilot study. Over half of Hispanics endorsed confusion about which skin cancer recommendations to follow, and significant proportions of Hispanics agreed with the statement "it seems likely almost everything causes skin cancer" (24%); and "people with skin cancer would have pain or other symptoms prior to diagnosis" (24%). Also in the investigators' prior work with nationally representative samples, the investigators found that Non-Hispanic Whites had higher awareness of accurate skin cancer causes, prevention strategies, and symptoms than Hispanics. Hispanics reported higher levels of information overload and misconceptions.
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